Paul A Cummins

Suggest Changes
Learn More
AIM The aim of the study was to determine whether a single intravenous infusion of 25 mg/kg CDP860, a humanized di-Fab' fragment against PDGF-beta receptor, leads to a reduction of in-stent(More)
  • 1